Loading...

Competing risks of death in younger and older postmenopausal breast cancer patients

AIM: To show a new paradigm of simultaneously testing whether breast cancer therapies impact other causes of death. METHODS: MA.14 allocated 667 postmenopausal women to 5 years of tamoxifen 20 mg/daily ± 2 years of octreotide 90 mg, given by depot intramuscular injections monthly. Event-free surviva...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:World J Clin Oncol
Main Authors: Chapman, Judy-Anne W, Pritchard, Kathleen I, Goss, Paul E, Ingle, James N, Muss, Hyman B, Dent, Susan F, Vandenberg, Ted A, Findlay, Brian, Gelmon, Karen A, Wilson, Carolyn F, Shepherd, Lois E, Pollak, Michael N
Format: Artigo
Sprog:Inglês
Udgivet: Baishideng Publishing Group Inc 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259936/
https://ncbi.nlm.nih.gov/pubmed/25493245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i5.1088
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!